Hemas Overview

  • Founded
  • 1948

  • Status
  • Public

  • Employees
  • 3,296

  • Stock Symbol
  • HHL.N0000

Stock Symbol
  • Investments
  • 6

  • Share Price
  • $0.20

  • (As of Wednesday Closing)

Hemas General Information


Hemas Holdings PLC holds investments in companies with diversified businesses in Sri Lanka. Its businesses include manufacturing, trading and distributing FMCG products, pharmaceutical products, healthcare products, provision of medical care, operating tourism business, hotel management, airlines, shipping business, IT solutions, among others. It operates in Consumer, Healthcare, Leisure, Travel & Aviation, Mobility, and Other segments. The healthcare segment which generates majority revenue distributes pharmaceuticals, surgical and diagnostics products, and owns and manages hospitals.

Contact Information

Formerly Known As
Hemas Drugs (Pvt.) Ltd.
Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Industries
Other Restaurants, Hotels and Leisure
Hospitals/Inpatient Services
Hotels and Resorts
Stock Exchange
Primary Office
  • 75, Braybrooke Place
  • Colombo, 00002
  • Sri Lanka
+94 0114 000 000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hemas Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.20 $0.19 $0.11 - $0.21 $121M 597M 364K $0.02

Hemas Financials Summary

In Thousands,
TTM 31-Dec-2022 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020
EV 117,461 70,376 269,837 222,364
Revenue 314,317 379,798 337,086 328,965
EBITDA 40,444 40,046 28,586
Net Income 13,061 20,469 17,002 6,770
Total Assets 254,187 255,947 314,859 336,362
Total Debt 62,151 22,028 34,457 49,620
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hemas Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hemas‘s full profile, request access.

Request a free trial

Hemas Executive Team (10)

Name Title Board Seat Contact Info
Kasturi Wilson Group Chief Executive Officer, Executive Director & Board Member
Zalmi Fazeel Group Chief Financial Officer
Rizny Faisal Director & Head, Group Mergers & Acquisitions and Strategy
Gavin Mudalige Manager, Group Mergers & Acquisitions and Strategy
Yusuf Nilamdeen Manager, Group Mergers & Acquisitions and Strategy
You’re viewing 5 of 10 executive team members. Get the full list »

Hemas Board Members (13)

Name Representing Role Since
000000 00000000 Hemas Non-Executive Chairman 000 0000
000000 00000000 Hemas Board Member 000 0000
0000000 000000 Hemas Group Chief Executive Officer, Executive Director & Board Member 000 0000
00000 0000000000 0 Self Independent Non Executive Director - Hemas Power PLC 000 0000
You’re viewing 4 of 13 board members. Get the full list »

Hemas Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hemas Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 000 01-Jan-2019 00000 0000 Logistics
00000 0000000 19-Jan-2018 0000000000 000.00 Business Equipment and Supplies 000000 00
00 00000 18-Apr-2017 0000000000 00000 Energy Infrastructure
0000000 30-May-2013 0000000000 000.00 Pharmaceuticals 000000 00
Upper Agra Oya Hydropower 01-Dec-2009 Buyout/LBO Other Energy
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Hemas Subsidiaries (2)

Company Name Industry Location Founded
Atlas Axillia Business Equipment and Supplies Peliyagoda, Sri Lanka 1959
0000000 Pharmaceuticals Colombo, Sri Lanka 0000
To view Hemas’s complete subsidiaries history, request access »

Hemas ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies



Industrial Conglomerates








To view Hemas’s complete esg history, request access »

Hemas Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000000 13-Nov-2005 0000 Completed
  • 4 buyers
To view Hemas’s complete exits history, request access »